Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • Legit.Health Plus Version 1.1.0.0
    • Index of Technical Documentation or Product File
    • Summary of Technical Documentation (STED)
    • Description and specifications
    • R-TF-001-007 Declaration of conformity
    • GSPR
    • Clinical
      • Evaluation
      • Investigation
        • 🗄 Drafts
        • R-015-005 Investigator's Brochure Legit.Health_acne
        • AIHS4 2025
        • BI 2024
        • COVIDX EVCDAO 2022
        • DAO Derivación O 2022
        • DAO Derivación PH 2022
        • IDEI 2023
        • MC EVCDAO 2019
        • PH 2024
        • SAN 2024
      • R-TF-015-008 Clinical development plan
    • Design and development
    • Design History File
    • IFU and label
    • Post-Market Surveillance
    • Quality control
    • Risk Management
    • Usability and Human Factors Engineering
  • Legit.Health Plus Version 1.1.0.1
  • Licenses and accreditations
  • External documentation
  • Legit.Health Plus Version 1.1.0.0
  • Clinical
  • Investigation

Investigation

🗃️ 🗄 Drafts

4 items

📄️ R-015-005 Investigator's Brochure Legit.Health_acne

Introduction

🗃️ AIHS4 2025

2 items

🗃️ BI 2024

3 items

🗃️ COVIDX EVCDAO 2022

3 items

🗃️ DAO Derivación O 2022

3 items

🗃️ DAO Derivación PH 2022

3 items

🗃️ IDEI 2023

3 items

🗃️ MC EVCDAO 2019

3 items

🗃️ PH 2024

3 items

🗃️ SAN 2024

3 items

Previous
R-TF-015-007 Delaration of interest Taig Mac Carthy
Next
🗄 Drafts
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI LABS GROUP S.L.)